SCHEMBL3488005

SCHEMBL3488005

CCCCCCOc1ccc(CCCCC(=O)C(F)(F)C(F)(F)F)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.63
S1PR4 O95977 2/20 0.53
S1PR1 P21453 2/20 0.53
S1PR3 Q99500 2/20 0.53
MEN1 O00255 1/20 0.52
USP2 O75604 1/20 0.52
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAPK1 P28482 1/20 0.52
CASP1 P29466 1/20 0.52
KMT2A Q03164 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
SLCO1B3 Q9NPD5 1/20 0.52
SLCO1B1 Q9Y6L6 1/20 0.52
S1PR5 Q9H228 1/20 0.51
PLA2G4A P47712 1/20 0.51
HDAC1 Q13547 3/20 0.49
HDAC2 Q92769 3/20 0.49
HDAC3 O15379 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3487625 0.96 FAAH (0.60) FAAHS1PR4S1PR1S1PR3MEN1
SCHEMBL3487844 0.92 S1PR1 (0.55) FAAHS1PR4S1PR1S1PR3MEN1
SCHEMBL3488416 0.90 FAAH (0.79) FAAHMEN1USP2ALDH1A1LMNA
SCHEMBL3487569 0.90 FAAH (0.79) FAAHMEN1USP2ALDH1A1LMNA
SCHEMBL3490532 0.86 FAAH (0.76) FAAHMEN1USP2ALDH1A1LMNA
SCHEMBL11837534 0.84 S1PR4 (0.60) S1PR4S1PR1S1PR3MEN1USP2
SCHEMBL4685776 0.83 S1PR4 (0.57) S1PR4S1PR1S1PR3MEN1USP2
SCHEMBL3487635 0.82 FAAH (0.65) FAAHS1PR4S1PR1S1PR3LMNA
SCHEMBL3488458 0.82 FAAH (0.65) FAAHS1PR4S1PR1S1PR3LMNA
SCHEMBL9663932 0.81 S1PR1 (0.67) S1PR4S1PR1S1PR3MEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048727-A1 PERFLUOROKETONE COMPOUNDS AND USES THEREOF DAVID SAMUEL 2010-02-25 US disclosed
US-20100048727-A1 PERFLUOROKETONE COMPOUNDS AND USES THEREOF DAVID SAMUEL 2010-02-25 US disclosed
EP-2139836-A1 PERFLUOROKETONE COMPOUNDS AND USES THEREOF The Royal Institution for the Advancement of Learning/McGill University (CA) 2010-01-06 EP disclosed
WO-2008122119-A1 PERFLUOROKETONE COMPOUNDS AND USES THEREOF THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2008-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048727-A1 PERFLUOROKETONE COMPOUNDS AND USES THEREOF PLA2G1B, PLA2G4B, PLA2G2E FAAH 26/4885S1PR4 311/4885S1PR1 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.